Core Viewpoint - The article discusses the strong rebound of domestic brands in sectors such as consumer goods, pharmaceuticals, and technology, driven by the logic of domestic brand substitution and independent performance growth, leading to increased market share and revenue opportunities for these brands [2][3]. Group 1: Domestic Brand Substitution Logic - Public funds have heavily invested in domestic brands, particularly in the cosmetics sector, benefiting from the domestic brand substitution logic, as foreign competitors like Estée Lauder face challenges in the Chinese market [3]. - The stock of Estée Lauder has seen a cumulative decline of over 25% in the last four trading days, while domestic brands like Mao Geping and Shangmei have shown strong resilience, with increases of 6.30% and 3.89% respectively [3]. - In the infant formula sector, domestic brand China Feihe has surged over 10% in the Hong Kong market, supported by significant investments from Ping An Fund and GF Fund [3]. Group 2: Independent Performance Growth - The article emphasizes the importance of independent performance, highlighting that many domestic brands achieve stable growth by relying on the vast domestic market, with companies like Bosideng generating approximately 94% of their revenue from China [6]. - The motorcycle sector has seen a surge in interest for domestic brand Chunfeng Power, with 70 public funds including it in their top ten holdings, reflecting confidence in the brand's growth potential [7]. - The article notes that many companies, including internet and consumer goods firms, have achieved consistent performance growth without international operations, indicating a strong domestic market drive [7]. Group 3: Market Opportunities and External Factors - The article points out that the strong manufacturing capabilities and demand in the domestic market provide public funds with opportunities to capitalize on undervalued stocks that have been unfairly punished by market sentiment [8]. - The pharmaceutical sector is expected to remain resilient against external factors, with domestic innovative drug companies benefiting from supportive policies and technological advancements [9][10]. - The article mentions that the introduction of zero tariffs on certain cancer and rare disease drugs in early 2024 may further mitigate external impacts on the pharmaceutical sector [10].

Core Viewpoint - The recent escalation of tariffs and countermeasures has put unprecedented pressure on import and export companies, but it also presents new opportunities for domestic brands as the focus shifts towards local consumption [1][2]. Group 1: Impact of Tariffs on International Brands - The introduction of tariffs has significantly affected international brands like Nike, which has seen its production costs in Vietnam, Indonesia, and China rise by over 30% [14][17]. - Nike's production in Vietnam has increased from 12% in 2019 to 51% currently, indicating a heavy reliance on this region for manufacturing [8]. - Adidas has experienced a decline in revenue in China, dropping from 45.46 billion yuan in 2018 to 30.97 billion yuan in 2024, with its market share decreasing from 20.74% to 13.08% [18]. Group 2: Opportunities for Domestic Brands - The shrinking market share of international brands due to tariffs creates opportunities for domestic companies to capture this market [23]. - Since 2018, domestic brands have gained traction, with 78.2% of consumers frequently purchasing local products [29]. - Li Ning has seen significant growth, with a revenue increase of 31.85% to 138.80 billion yuan in 2019, and its stock price surged nearly 20 times from 5 HKD to 102 HKD [31][33]. Group 3: Future Market Dynamics - The Chinese sports market is expected to grow, with the government aiming for the sports industry to reach a total scale of 5 trillion yuan by 2025 [41]. - The focus on domestic demand and innovation will likely become the main development line for companies in the face of international trade tensions [50]. - Investors are encouraged to focus on companies with high localization of revenue and competitive advantages in the domestic market [51].